We have updated the ordering process to allow all products and services to be purchased with a single PO, please address all POs to Horizon Discovery Biosciences Limited. Contact us for assistance.

Horizon Discovery Ltd. signs second commercial agreement with Genentech Inc.

01 Dec 2007

Horizon Discovery (Horizon) has signed a second commercial agreement to supply leading US biotechnology company Genentech, Inc. with access to its OncoGene panel of isogenic cell-lines.

The financial terms of both deals remain confidential but involve payment of up-front, annual renewal and milestone payments.

Chris Torrance, Horizon CSO says: “We are delighted to have Genentech as an early-adopter of the OncoGene panel. The licensed cell-lines in this panel represent novel drug discovery tools that accurately model specific genetic mutations observed in real human cancer cells”.